The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Co-occurrence of targetable aberrations in non-small cell lung cancer patients harboring MAP2K1 mutations.
 
Alessandra Holzem
No Relationships to Disclose
 
Lucia Nogova
Honoraria - Celgene; Pfizer
Consulting or Advisory Role - Boehringer Ingelheim; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis; Pfizer
 
Michaela A. Ihle
No Relationships to Disclose
 
Claudia Wompner
No Relationships to Disclose
 
Elisabeth Bitter
No Relationships to Disclose
 
Sebastian Yves Friedrich Michels
Honoraria - AstraZeneca; Boehringer Ingelheim; Novartis; Pfizer
Consulting or Advisory Role - Boehringer Ingelheim; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis
 
Rieke Nila Fischer
No Relationships to Disclose
 
Anna Kron
No Relationships to Disclose
 
Ulrich Gerigk
No Relationships to Disclose
 
Jens Kern
No Relationships to Disclose
 
Britta Kaminsky
No Relationships to Disclose
 
Winfried Randerath
No Relationships to Disclose
 
Joachim Lorenz
No Relationships to Disclose
 
Karl-Otto Kambartel
No Relationships to Disclose
 
Sabine Merkelbach-Bruse
No Relationships to Disclose
 
Reinhard Büttner
No Relationships to Disclose
 
Matthias Scheffler
No Relationships to Disclose
 
Juergen Wolf
No Relationships to Disclose